Universe Pharmaceuticals Inc (UPC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $7.59M
Last updated: Nov 17, 2026 at 8:19 AM ET
Earnings
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 59.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 25.9, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about UPC
News
UPC Valuation
- P/FCF
- -0.1x
- P/B
- 0.0x
UPC Profitability: Margins, ROIC and FCF
Universe Pharmaceuticals (UPC) has an operating margin of -11.8% and a net margin of -11.0%. It posts a -70.0% FCF margin.
- Operating margin
- -11.8%
- Net margin
- -11.0%
- ROE
- -3.5%
- FCF margin
- -70.0%
- FCF yield
- -1542.5%
Universe Pharmaceuticals Competitors
The companies most similar to Universe Pharmaceuticals (UPC) include InMed Pharmaceuticals, Biofrontera and cbdMD.
Sector: Healthcare
UPC Bull Case vs Bear Case
Bear case
- UPC has a -11.0% net profit margin.
- UPC's quarterly revenue changed -1.3% year over year.
Updated Aug 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About UPC
Does UPC pay dividends?
Universe Pharmaceuticals Inc (UPC) does not currently pay a regular dividend.
What is UPC's market cap?
Universe Pharmaceuticals Inc (UPC) has a market capitalization of $7.59M with a current stock price of $1.43.
UPC pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.